Research theme(s)

Evaluation of medication use, effectiveness and safety

Keywords

Research summary

Pharmacoepidemiological studies of medications used in the treatment of various conditions (schizophrenia, depression, anxiety, attention deficit hyperactivity disorder, autism, and hepatitis C). Additional research projects explore the use of smoking cessation agents, patients’ perspective regarding effectiveness of medications, vaccines and health services, and the risks of neurological disorders in newborns/young children prenatally/perinatally exposed to antibiotics.

More recent projects explore the delivery of health care services to refugees in Canada, and the effects of antipsychotic therapy in patients interacting with the justice system.  Collaborations with the pan-Canadian network CNODES include population-based studies on the effects of antipsychotic and antidiabetic agents.

Biography

Currently a professor at the College of Pharmacy, Rady Faculty of Health Sciences and Adjunct Scientist, Manitoba Centre for Health Policy. Dr. Alessi-Severini has worked extensively for provincial governments providing advice on reimbursement of new prescription medications approved for the Canadian market.

She has served on numerous provincial and national advisory committees (e.g., Manitoba Drug Standards and Therapeutics Committee, Canadian Drug Expert Committee) and is a member of the Manitoba team of the Canadian Network for Observational Drug Effect Studies (CNODES).

Dr. Alessi-Severini has received internal and external funding from various agencies including CIHR.

Education

Awards

Recipient of the Leslie Buggey Professorship and the Ed Kroeger Mentorship Award.

ORCID profile

Visit Silvia Alessi-Severini's ORCID profile for a complete listing.

Silvia Alessi-Severini's profile